Skip to main content
. 2015 Mar 26;6(15):13255–13268. doi: 10.18632/oncotarget.3658

Table 2. Correlation between clinicopathologic variables and immunohistochemical expression of Btk in malignant ovarian cancer patients.

Clinical parameters Variables No of patients Btk expression χ2 Odds ratio p value
Lown n (%) Highn n (%)
Age (years) ≥60 8 4 (50) 4 (50) 0.498 1.778 0.4806
<60 25 9 (36) 16 (64)
Metastasis No 24 12 (50) 12 (50) 4.146 8.00 0.0417
Yes 9 1 (11.11) 8 (88.89)
Stage I/II 21 11 (52.38) 10 (47.62) 4.080 5.50 0.0434
III/IV 12 2 (16.67) 10 (83.33)